Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review
Although nanomedicine has been highly investigated for cancer treatment over the past decades, only a few nanomedicines are currently approved and in the market; making this field poorly represented in clinical applications. Key research gaps that require optimization to successfully translate the u...
Main Authors: | Xue Bai, Zara L. Smith, Yuheng Wang, Sam Butterworth, Annalisa Tirella |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Micromachines |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-666X/13/10/1623 |
Similar Items
-
Microfluidics Technology for the Design and Formulation of Nanomedicines
by: Eman Jaradat, et al.
Published: (2021-12-01) -
FRET Ratiometric Nanoprobes for Nanoparticle Monitoring
by: Guangze Yang, et al.
Published: (2021-12-01) -
MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
by: Deyssy Patrucco, et al.
Published: (2020-08-01) -
Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment
by: Enrique Niza, et al.
Published: (2021-07-01) -
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
by: Foad Rommasi, et al.
Published: (2021-05-01)